Previous Article | Next Article 
Journal of Virology, September 2001, p. 7995-8007, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.7995-8007.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Specific Interaction of a Novel Foamy Virus Env
Leader Protein with the N-Terminal Gag Domain
Thomas
Wilk,1,2
Verena
Geiselhart,3
Matthias
Frech,4
Stephen D.
Fuller,1,2
Rolf M.
Flügel,3 and
Martin
Löchelt3,*
Structural Biology Programme, European Molecular Biology
Laboratory,1 and Abteilung Retrovirale
Genexpression, Forschungsschwerpunkt Angewandte Tumorvirologie,
Deutsches Krebsforschungszentrum,3 Heidelberg,
and Merck KGaA, D-64293 Darmstadt,4
Germany, and Division of Structural Biology, Wellcome Trust
Centre for Human Genetics, University of Oxford, Oxford, United
Kingdom2
Received 12 March 2001/Accepted 31 May 2001
 |
ABSTRACT |
Cryoelectron micrographs of purified human foamy virus (HFV) and
feline foamy virus (FFV) particles revealed distinct radial arrangements of Gag proteins. The capsids were surrounded by an internal Gag layer that in turn was surrounded by, and separated from,
the viral membrane. The width of this layer was about 8 nm for HFV and
3.8 nm for FFV. This difference in width is assumed to reflect the
different sizes of the HFV and FFV MA domains: the HFV MA domain is
about 130 residues longer than that of FFV. The distances between the
MA layer and the edge of the capsid were identical in different
particle classes. In contrast, only particles with a distended envelope
displayed an invariant, close spacing between the MA layer and the Env
membrane which was absent in the majority of particles. This indicates
a specific interaction between MA and Env at an unknown step of
morphogenesis. This observation was supported by surface plasmon
resonance studies. The purified N-terminal domain of FFV Gag
specifically interacted with synthetic peptides and a defined protein
domain derived from the N-terminal Env leader protein. The specificity
of this interaction was demonstrated by using peptides varying in the
conserved Trp residues that are known to be required for HFV budding.
The interaction with Gag required residues within the novel
virion-associated FFV Env leader protein of about 16.5 kDa.
 |
INTRODUCTION |
The genomes of spumaretroviruses (or foamy
viruses [FV]) include the classical gag, pro-pol, and
env genes that are the hallmark of the retrovirus family
(9). Despite the familial relationship implied by their
genome organization, FV differ from retroviruses such as oncoviruses or
lentiviruses in basic aspects of replication and gene expression
(30-32, 39, 53). The differences between FV and the more
widely studied retroviruses, such as human immunodeficiency virus (HIV)
or murine leukemia virus, provide an opportunity to identify the
fundamental mechanisms of processes such as particle assembly and maturation.
The shared gene order of the FV genomes and those of other retroviruses
allows the identification of common structural proteins. Unfortunately,
this relationship does not extend to the structure and function of FV
Gag proteins, since no obvious homologies are detectable between FV Gag
and MA, CA, and NC domains of other retroviruses for which structures
have been determined to high resolution (10, 43).
Furthermore, the proteolytic processing of Gag that produces the
familiar mature proteins in other retroviruses is unusual, incomplete,
and/or delayed in FV (12, 23, 29, 37).
The available data indicate that the morphology and morphogenesis of FV
are distinct from those of other retroviruses. FV Gag proteins
preassemble to form in the cytoplasm spherical capsids that bud through
cellular membranes (55). This process contrasts with what
occurs with lentiviruses and C-type retroviruses that assemble their
capsids at the site of budding but is similar to what occurs with B-
and D-type retroviruses (40). Budding of human foamy virus
(HFV) is strictly dependent upon the presence of Env proteins (4,
38), while budding of the other retroviruses occurs in the
absence of Env. Recent results indicate that the Env leader protein
(Elp) of HFV is the region that supports budding (D. Lindemann,
personal communication). Electron microscopy (EM) of thin sections did
not reveal the condensation of the ring-like capsids in FV particles
after budding which is characteristic for the maturation of other
retroviruses. Rearrangements of the FV capsids were rarely observed
(34) or may not occur (14, 55). This lack of
morphological maturation has been attributed to the incomplete
processing of FV Gag proteins described above.
Cleavage of Gag in other retroviruses is believed to modulate its
affinity for the membrane by altering the exposure of an amino-terminal
acyl moiety and other motifs in MA (16, 57). The lack of
complete proteolytic cleavage and the absence of basic sequence and
myristylation motifs in MA that mediate membrane targeting in other
retroviruses suggest that FV must bind to membranes by other mechanisms.
We combined cryoelectron microscopy (cEM) studies of HFV and feline
foamy virus (FFV) particles with biosensor surface plasmon resonance
(SPR) analyses of FV proteins to address the issues of Gag-membrane
interaction. cEM has previously been used to demonstrate the lack of
icosahedral symmetry and presence of local order in HIV and murine
leukemia virus (20, 52), and it has revealed the radial
arrangement of the Gag polyproteins and allowed the mapping of the
positions of individual domains in HIV type 1 Gag (48,
49). In FV particles, Gag proteins are radially arranged inside
the virions, and lateral interactions of Gag domains result in the
formation of the MA layer and the FV capsid shell. An intimate association of the Gag MA layer and the viral membrane was detected in
20% of FFV particles. SPR technology demonstrated a direct and
specific physical interaction of the FFV Elp with the N terminus of
Gag. This result and the detection of the 16.5-kDa FFV Elp in released
virions suggest a putative transient interaction of the MA layer and
Elp during particle morphogenesis of FV.
 |
MATERIALS AND METHODS |
Cells and virus.
Crandell feline kidney (CRFK) and HEL299
cells were grown as reported previously (50). FFV isolate
FUV and the prototypic HFV were propagated as described previously
(33, 50).
Purification of released FV particles.
Cell culture
supernatants from HFV-infected HEL299 or FFV-infected CRFK cells were
harvested 4 to 6 days after infection, when the infected cells
displayed strong virus-induced cytopathic effects. Cell culture
supernatants were cleared by centrifugation at 400 × g
for 7 min and then at 3,000 × g for 30 min
(46). Supernatants were filtered through 440-nm-pore-size
filters and centrifuged through 5 ml of 20% (wt/vol) sucrose in TEN
(150 mM NaCl, 10 mM Tris/HCl [pH 8.0], 1 mM EDTA) for 2 h at
24,000 rpm in an SW27 rotor (Beckman, Munich, Germany). The resulting
pellet was gently resuspended in phosphate-buffered saline. For further purification, the enriched particles were separated on sucrose gradients (48) or banded in a preformed 10 to 32%
iodixanol (Optiprep; Nycomed Pharma, Oslo, Norway) gradient in TEN run
for 16 h at 32,000 rpm in an SW41 rotor (Beckman)
(3).
cEM, image analysis, and contrast transfer function
correction.
cEM was performed as described previously using a
Philips CM200FEG operated at 200 kV at a magnification of ×38,000
(20, 49). The images were digitized on a Zeiss
(Oberkochen, Germany) SCAI scanner at a step size of 14 µm. The
measurements shown in Fig. 4 were performed using the SPIDER image
analysis program (15). The particle diameter was measured
from the outer leaflet of the membrane and thus excludes the
contribution of the projection domains of the viral glycoproteins.
The defocus of the micrograph was determined from the positions of the
local minima in a radially averaged power spectrum. Contrast transfer
function (13) correction was performed by division of the
transform of the image with the appropriate phase contrast transfer
function as described previously (11).
Expression and purification of recombinant FFV Gag and Elp.
FFV Gag residues 1 to 154 were bacterially expressed in the pET16b
(Novagen, Madison, Wis.) vector as described previously (5). The FFV Gag residues 1 to 154 were flanked at the N
terminus by the vector-encoded His tag and 16 unrelated residues at the C terminus. Induced Escherichia coli BL21 cells were lysed
in IMAC buffer in the absence of urea or other denaturing agents by
sonification (5). The soluble recombinant FFV Gag 1 to 154 was purified to more than 95% homogeneity using Ni affinity
chromatography, dialyzed against phosphate-buffered saline, and stored
at
70°C before use. Elp residues 1 to 65 were amplified by PCR with
primers 5'-GCTCATGATGGAACAAGAACATGTG-3' (the
introduced BspHI site is underlined) and
5'-GGAATTCTCATCTAGTAGAAGTAGCACA-3' (the
introduced EcoRI site is underlined) as described previously
(55). The amplicon was digested with BspHI and
EcoRI and inserted into the NcoI- and
EcoRI-digested vector pET32c (Novagen). The resulting thioredoxin-Elp fusion protein of 25 kDa and the pET32c-derived thioredoxin control protein were purified to about 90% homogeneity under nondenaturing conditions by His tag affinity chromatography as
described above.
Immunoblotting and induction of an Elp-specific antiserum.
Immunoblotting of proteins separated on denaturing gels and detection
of specifically bound antibodies by enhanced chemiluminescence and
diamino-benzidine staining were done as described previously (1,
37). Synthesis of authentic and mutant Elp-derived peptides was
as recently described (37). A synthetic peptide
encompassing the authentic FFV Env residues 1 to 30 was directly used
for immunization of guinea pigs by Eurogentec, Seraing, Belgium. The
FFV MA and Env surface (SU) antisera and cat antiserum 8014 were as described previously (1, 5, 56).
Binding analysis by SPR.
Protein interactions were
identified and characterized by SPR technology using the BIAcore 3000 instrument (BIAcore, Freiburg, Germany) and methodology (26,
27). Coupling reagents were used according to protocols
developed by the supplier.
Coupling to the CM5 sensor chip was done via activated carboxylate
groups to amine groups of the recombinant FFV Gag 1 to
154 protein (Gag
1-154) which was purified to homogeneity as described.
Analysis of the
pH dependence of protein coupling (pH scouting)
and the coupling
chemistry were performed under standard conditions
(
26,
27). The purified FFV Gag 1-154 protein was diluted into
10 mM
acetate buffer (pH 4.5) to a final concentration of 20 µg/ml
for
coupling to the sensor chip. After the coupling chemistry,
about 1,500 relative response units as base signal were immobilized
on the sensor
chip and gave a stable signal. The Elp peptides
and the recombinant Elp
protein were dissolved in 10 mM HEPES
(pH 7.4)-150 mM NaCl-3 mM
EDTA-0.005% Tween 20 (HBS buffer) for
binding analyses. Binding
experiments were performed in HBS buffer
at 25°C. For each
protein analyzed, a single chip was employed
and measurements were done
twice and in duplicate. Peptide concentrations
were varied from 0.78 to
50 µg/ml, corresponding to 2 × 10
7 to
1.33 × 10
5 M. Reverse experiments in
which the recombinant Elp protein and
Elp-derived peptides were coupled
to sensor chips and probed with
recombinant FFV Gag1-154 were performed
under similar conditions.
SPR data analysis was done with the
integrated BIAcore 3000
software.
A bacterially expressed HIV-1 MA protein encompassing residues 1 to 132 was purified by ion-exchange chromatography and gel
filtration and
served as control (T. Wilk, unpublished data).
An antiserum directed
against HIV-1 MA was kindly provided by
H.-G. Kräusslich,
Heidelberg,
Germany.
 |
RESULTS |
cEM of released enveloped and nonenveloped HFV particles.
HFV
particles released into the supernatant of infected cells were
harvested and concentrated by sedimentation through sucrose. This
protocol isolated enveloped HFV particles that were heterogeneous in
size and shape together with some cell debris. The virions ranged in
size between 55 and 250 nm and displayed a mean membrane-included diameter of 106.9 ± 8.3 nm (mean ± standard
deviation) (n = 48) (Table 1).
The particles were covered with spikes 15.6 ± 2.1 nm long
(n = 83) that formed clusters on the virion surfaces
(46). Capsid structures with diameters of
60 nm were
present within the enveloped particles. The enveloped capsids were
neither completely spherical nor regular but appeared angular without
any apparent symmetry.
Spherical, nonenveloped particles with diameters of

60 nm were also
present in supernatants of HFV-infected cells (data not
shown). These
spherical particles resembled the capsids observed
within the enveloped
virions and may represent preassembled intracellular
capsids that had
been released by cell lysis (
4,
14,
29,
34,
55).
Organization of HFV particles.
HFV particles purified by an
additional sucrose centrifugation step (see Materials and Methods)
banded at a density of approximately 1.16 g/ml, similar to that
described for other retroviruses (45). Spherical HFV
particles with tightly packed spikes (Fig. 1B) inserted into the viral membrane (Fig. 1A) predominated in this purified material (for a schematic presentation, see Fig. 1C and 2D). The projecting region of the spike displayed a layered appearance that was
most apparent within the spike clusters, suggesting that the structural
features of the Env complexes were laterally aligned in the clusters
(Fig. 1B). A fraction of the particles displayed a distorted membrane
and an asymmetric distribution of Env proteins and even contained two
capsids as discussed below in detail for FFV.

View larger version (117K):
[in this window]
[in a new window]
|
FIG. 1.
Ultrastructure of released HFV particles (A to C) and
schematic alignment of HFV and FFV Gag proteins (D). cEM of HFV reveals
closely packed envelope proteins with distinct layers of density within
the glycoproteins (pair of black arrows in B) covering the surface of
the budded virion. A separation between the viral membrane (pair of
white arrows) and the broad MA layer (white bracket and white
arrowhead) is clearly visible and characteristic for budded FV
particles. The MA layer width of about 8 nm is characteristic for HFV.
The prominent margin of the angular HFV capsid is marked with a black
arrowhead. The capsid in panel A has a central position in contrast to
the off-center position of the capsid shown in panel B. The scale bar
in panel B represents 50 nm. (C) Schematic presentation of structural
features of HFV particles analyzed by cEM. (D) Schematic alignment of
HFV and FFV Gag proteins. The presence of the C-terminal p3 cleavage
site (arrow), the p3 protein, and the N-terminal, Pro-rich (P-rich),
and central and C-terminal subdomains of FV Gag proteins is shown. For
details, see the text.
|
|
cEM revealed that the majority of HFV particles contained one angular,
isometric capsid (Fig.
1A, black arrowhead pointing
to the edge of the
capsid) that was centered in the particle.
Standard common line methods
(
2,
13a,
18,
19) provided
no evidence of icosahedral
symmetry in the isometric particles
of the preparation. In some HFV
particles, the angular capsids
were displaced toward the periphery
(Fig.
1B).
HFV capsids were surrounded by a protein layer 8.2 ± 0.9 nm wide
which maintained a relatively fixed distance to the body
of the capsid
(Fig.
1). We will refer hereafter to this protein
layer as the
MA layer in analogy to the region which separates
the capsid from the
membrane in immature retroviruses (
45,
49).
In order to
determine whether this MA layer is common to other
FV, virus particles
from the distantly related FFV were analyzed
by
cEM.
The width of the MA layer is characteristic for different FV.
Enveloped FFV particles measured 109.1 ± 11.2 nm
(n = 55) in diameter and banded at a density of 1.16 g/ml. Surface staining of isolated FFV particles showed tightly packed
glycoprotein complexes (data not shown) similar to those described
previously for HFV (46). cEM analysis showed the spikes as
projections 14 ± 2 nm (n = 103) long, with strong
lateral interactions resulting in the formation of clusters as also
observed in HFV. FFV particles contained an angular capsid of 63.5 ± 7.8 nm (n = 90) (Table 1 and Fig.
2D). Capsids were always separated from the viral
membrane by a protein layer resembling the MA layer of HFV (Fig. 1 and 2). The thickness of the MA layer between the capsid and the viral envelope was the only consistent difference between HFV and FFV particles. Close examination of a large number of virions revealed an
MA layer consistently thinner in FFV (3.8 ± 0.7 nm
[n = 65]) than in HFV (8.2 ± 0.9 nm
[n = 62]) (Table 1). This difference in the sizes of
the MA layers may correspond to 130 additional residues in the
N-terminal region of HFV compared with FFV (Fig. 1D) (42,
50).

View larger version (184K):
[in this window]
[in a new window]
|
FIG. 2.
Ultrastructure of released FFV particles (A to C) and
schematic diagram of FFV particles (D). The MA layer (white arrowheads)
follows the shape of the capsids in particles with central (A) and
off-center (B) capsids as schematically shown in panel D. Many
particles in the population show the internal angular capsid (the edge
of the capsid is marked by black arrowheads) displaced from the center
of the particle (B). Views in which the capsid appeared to be almost in
the center of the particle were also observed (A). Occasionally, two
capsids were surrounded by an almost perfect spherical viral membrane
(pair of white arrows), resulting in particles with a greater diameter
(B and C).
|
|
Localization of the MA layer in distinct classes of FFV
particles.
In 25% of the FFV particles analyzed, the isometric,
angular capsid was positioned in the center of the particle (Fig. 2A). The MA layer appeared to follow the edge of the capsid, resulting in a
variable distance between the MA layer and the viral membrane. That the
FFV MA layer followed the shape of the capsid and was not associated
with the viral membrane was more obvious when the capsid was displaced
from the center of the particle (Fig. 2B). Such particles with
off-center capsids represented 50% of the virus population. The ratio
of central to off-center capsid locations suggests that they arise from
the same particle morphology (i.e., an off-center capsid) viewed from
different directions in cEM. About 5% of the particles contained two
displaced capsids. In these particles, the MA layer maintained a
relatively fixed distance to the body of the capsid with no obvious
physical interaction with the viral membrane (Fig. 2C). In both
particle types described above, the MA layer appeared to be separated
from the viral membrane but was consistently localized next to the
angular viral capsid as schematically shown in Fig 2D.
About 20% of the FFV particles displayed a distended morphology: their
envelopes were distended and incompletely closed, and
the particles
were thus composed of a spherical portion and a
protruding tail (Fig.
3). These particles with distended morphology
displayed
strong evidence for an interaction of the MA layer with
the viral
membrane. The MA layer was located significantly closer
to the viral
membrane than in the FFV particles with a central
or off-center capsid
described above (Table
2). In addition,
the similar
periodicities of the projections on the particle surface
and the inner
structural components suggest an interaction between
the Gag proteins
and components of the viral membrane. Particles
with a corresponding
morphology were also found in HFV (not shown).

View larger version (220K):
[in this window]
[in a new window]
|
FIG. 3.
Features of FFV particles with a distended morphology.
Particles with a distended morphology (A to D) show tight interaction
of the MA layer (white arrowheads) with the viral membrane (pair of
white arrows). The two opposed arrows mark the stalk of cellular
membrane which is still attached to the particle (B). The pairs of
black arrows mark spike proteins, and the black arrowheads point to the
margin of the capsid. The scale bar in panel D represents 50 nm.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Relative abundance of different FFV particle morphologies
and distances between the MA layer and the capsid and between the MA
layer and the viral membrane in defined FFV particle types
|
|
We measured the distances between the MA layer and the viral membrane
and between the MA layer and the capsid layer to define
the different
morphology of the distended particles. The spacing
between the membrane
and the MA layer and between the MA layer
and the capsid was measured
at 1-nm intervals along the circumference
of the MA layer in different
types of particles. The measurements
of individual particles
demonstrate the constant distance between
the capsid and the MA layer
over several microns of arc (Fig.
4A). The spacing was
unchanged between FFV particles that displayed
central capsids,
off-center capsids, or the distended morphology
(Fig.
4A). In contrast,
only particles with the distended morphology
maintained a constant
distance between the MA layer and the viral
membrane (Fig.
4B). The
distance differed by up to 100% for particles
with central capsids and
by up to 300% for the off-center ones.
The average values of these
measurements using six different particles
for each of the different
virus morphologies are given in Table
2: the MA layer is very closely
opposed to the viral membrane
in distended forms, while both structures
are significantly further
separated from each other in particles with
central and off-center
capsids. While the interaction between the
membrane and the MA
layer is evident only in distended particles, the
constant spacing
between the MA layer and the capsid is maintained in
each of the
different particles, suggesting a tight and invariant link
between
the subunits of the MA layer and the viral capsid.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Relative localization of the MA layer in FFV particles.
Arrangement of the MA layer in FFV particles with central capsids
(diamonds), off-center capsids (squares), and distended morphology
(triangles). The plots show the distribution of distances between the
MA layer and the edge of the capsid structure (A) and between the MA
layer and the inner leaflet of the viral membrane (B). The distances in
nanometers are plotted against the position of the measurement on the
circumference of the MA layer and were measured at 1-nm intervals. A
typical result is shown for each particle type. No significant
difference is seen between the mean distances from the capsid to the MA
layer of the three particle types (A). In contrast, only the distended
FFV particles showed a constant and close juxtaposition between the MA
layer and the membrane, with a distance of 6.0 ± 0.8 nm
(mean ± standard deviation) (n = 83) (B). The
mean distances from the membrane to the MA layer were 8.8 ± 1.4 nm (n = 85) for central capsids and 18.3 ± 11.4 nm (n = 133) for off-center capsids.
|
|
The FFV Elp is virus associated.
Recent results demonstrate
that the N terminus of HFV Env is required for particle budding and
that this domain is cleaved off as a protein of about 148 residues by
an unknown protease (D. Lindemann, personal communication). We analyzed
whether a corresponding Elp is present in FFV, since this domain may be responsible for the Gag-envelope interaction seen in cEM of distended FFV particles. FFV particles enriched by centrifugation through sucrose
and FFV antigen from infected CRFK cells were subjected to
immunoblotting using the FFV Env SU antiserum directed against Env
residues 101 to 402 and the FFV Elp serum directed exclusively against
Env residues 1 to 30 (Fig. 5). The Elp antiserum
detected exclusively FFV proteins of about 16.5 kDa in
virion-associated antigens, which corresponds in size to the expected
FFV Elp protein (Fig. 5B, lane 4). In extracts from FFV-infected cells,
the Elp antiserum specifically detected the unprocessed Env precursor of 130 kDa and the 16.5-kDa Elp (Fig. 5B, lane 2) besides an unspecific band also present in mock-infected cells (lane 3). The FFV Env SU serum
detected the 16.5-kDa Elp and the 70-kDa Env SU bands in enriched FFV
virions (Fig. 5A, lane 4). At the antigen concentration used, the Env
SU serum did not allow detection of the FFV Elp protein in FFV-infected
cells (lane 2) whereas the Env precursor and the Env SU proteins were
recognized in addition to a few weak and unspecific bands.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
Detection of FFV Elp in released FFV particles and
FFV-infected cells. FFV particles were enriched from the cell culture
supernatant from FFV-infected CRFK cells by centrifugation through
sucrose as described in Materials and Methods, lysed, separated on a
denaturing gel, and analyzed by immunoblotting (lanes 4). In parallel,
proteins from FFV-infected (lanes 2) and mock-infected CRFK cells
(lanes 3) were analyzed. The blots were reacted with the FFV SU
antiserum (A) (56) and the FFV Elp antiserum (B)
and specific proteins were detected by diamino-benzidine staining (A)
and enhanced chemiluminescence (B). The positions of Elp, Env-SU, and
the gp130Env precursor are marked. Two different prestained
molecular mass markers were used in lanes 1. The gel in panel A
contained 16% polyacrylamide, and that in panel B contained 14%
polyacrylamide.
|
|
We then enriched FFV particles by centrifugation through 20% sucrose
and subsequently analyzed them by sedimentation into
a preformed
iodixanol gradient. Regular aliquots of the fractionated
gradient were
analyzed by immunoblotting using the FFV-specific
cat antiserum 8014 (
1) and the FFV Elp antiserum (Fig.
6).
The
cat antiserum detected a peak concentration of FFV p52 and
p48 Gag
proteins in fractions 5 and 6 corresponding to a density
of about 1.12 g/ml, similar to that reported for HFV particles
(
3). The
16.5-kDa Elp protein copurified into the same gradient
fractions as
seen with both antisera used (Fig.
6).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 6.
Cosedimentation of FFV Elp with FFV particles. FFV
particles enriched by centrifugation through 20% sucrose were analyzed
on preformed 10 to 32% iodixanol gradients as described in Materials
and Methods. Regular aliquots of the gradient fractions (as indicated)
were directly analyzed by immunoblotting using the FFV-specific cat
antiserum 8014 (A) and the FFV Elp antiserum (B). Proteins were
detected by enhanced chemiluminescence. The positions of the p52 and
p48 Gag and the FFV Elp proteins are marked. In lanes M,
prestained molecular mass markers were separated in parallel.
|
|
Preliminary studies using the bacterial protease subtilisin to digest
proteins which copurify with virions or which are located
on the
surfaces of particles indicate that Elp is an integral
component of FFV
particles: the N-terminal half of Elp is subtilisin
resistant, since
this part of Elp is located inside the virion
and thus not accessible
to the protease (data not shown). These
data demonstrate that the
mature 16.5-kDa Elp protein is present
in FFV virions. The Elp domain
is not part of the mature virion-associated
Env SU, whereas it is
initially part of the unprocessed Env precursor
in infected cells.
Importantly, the N terminus of Elp is located
inside the FFV
particle.
Specific interaction of the N-terminal domains of FFV Gag and Elp
determined by SPR.
The close association between the MA layer and
Env-bearing membrane regions described above for distended FFV
particles may reflect a specific interaction between defined regions in
Gag and Env. We used SPR to identify and characterize putative
interactions between a portion of the N-terminal FFV Elp and the
N-terminal region of the Gag polyprotein.
A bacterially expressed and purified recombinant N-terminal FFV Gag
protein (residues 1 to 154) was immobilized on the sensor
surface and
probed with synthetic peptides comprising the N-terminal
30 residues of
Env. At a peptide concentration of 50 µg/ml, this
assay demonstrated
specific binding of the wild-type (wt) peptide
WW (Fig.
7). Elp peptides with alanine substitutions for either
the first Trp (W12A) or both Trps (W12A, W15A) (peptides AW and
AA,
respectively) did not bind Gag 1-154 at the concentration
of 50 µg/ml. Substitution of Ala for the second Trp (peptide WA)
reduced binding to 14% of that obtained with the authentic FFV
Elp
peptide. No interaction was detected with an unrelated peptide
derived
from human collagen (Fig.
7).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 7.
Interaction of FFV Elp-derived peptides with FFV Gag
1-154. SPR analysis of the binding of FFV Elp-derived peptides to the
recombinant N-terminal FFV Gag 1-154 domain bound to the sensor
surface. Each peptide solution (50 µg/ml) was passed over the FFV Gag
sensor surface at a flow rate of 10 µl/min for 3 min. The peptide
representing the wt FFV (Elp residues 1 to 30) is designated WW, AW
represents the single W12A, WA represents the W15A exchange, and both
Trp residues have been replaced by Ala in peptide AA. A human
collagen-derived peptide (unrelated peptide) served as an additional
control. The signals for binding were automatically recorded after the
binding reaction reached equilibrium and are presented as relative
response units.
|
|
Kinetic analyses of the interaction of recombinant FFV Gag with
increasing concentrations of the wt Elp-derived peptide WW
showed a
clear dose dependence. The rapid association and dissociation
of the
peptide indicate a specific but relatively low affinity
interaction
(Fig.
8A). The half-life for the
dissociation was
estimated to be less than 5 s. Assuming a direct
and hyperbolic
function for the Elp peptide-MA interaction (
26,
27), a dissociation
constant of 1.52 × 10
5 M for the wt WW Elp peptide was calculated.
Comparable dissociation
constants and rapid on and off rates have been
reported for the
interaction of major histocompatibility complex
proteins with
defined peptide ligands (
25,
41).
Corresponding dissociation
constants could not be determined for the
mutant peptides by SPR,
since their binding was significantly weaker or
even absent (Fig.
7). The recombinant FFV MA protein used was
accessible for molecular
interactions, since the corresponding
antiserum directed against
this FFV Gag domain yielded a strong and
specific interaction
(Fig.
8B). The association of the MA antiserum
with the corresponding
membrane-bound MA protein was dose and time
dependent, with a
relatively stable binding signal over several minutes
of measurement,
indicating that the binding was strong and specific
(Fig.
8B).


View larger version (39K):
[in this window]
[in a new window]
|
FIG. 8.
(A) Kinetic analyses of the interaction of the authentic
Elp-derived peptide with FFV Gag 1-154 coupled to the CM5 sensor. The
peptide WW was passed over the sensor chip at a flow rate of 10 µl/min for 2.5 min at concentrations ranging from 2.08 × 10 7 to 1.33 × 10 5 M as shown in the
inset. The fast associations and dissociations are graphically
expressed as relative response over time in minutes. Regeneration of
the sensor surface was complete and achieved by changing to HBS buffer.
Arrow, start of the binding reaction; asterisk, beginning of the
washing with HBS buffer. (B) Kinetic analyses of the interaction of the
FFV MA antiserum with FFV Gag 1-154 coupled to the CM5 sensor. Defined
dilutions of the FFV MA antisera ranging from 1:500 to 1:8,000 were
passed over the sensor chip at a flow rate of 10 µl/min for 2.5 min
corresponding to immunoglobulin G concentrations from 14 to 0.88 µg/ml as shown in the inset. The slow association of the polyclonal
antiserum at concentrations reaching saturation and the very low
dissociation of the bound antibodies are graphically expressed as
relative response over time in minutes. (C) Kinetic analyses of the
interaction of the FFV Gag 1-154 protein coupled to the CM5 sensor
with the purified thioredoxin-Elp 1-65 fusion protein. Defined
concentrations of the recombinant thioredoxin-Elp 1-65 fusion protein
ranging from 62 to 15.5 µg/ml were passed over the sensor chip at a
flow of 15 µl/min for 3 min. The slow and specific association of the
thioredoxin-Elp 1-65 and the slow dissociation of the bound Elp
protein are graphically expressed as relative response over time in
minutes. The thioredoxin protein without the FFV Elp domain did not
show any specific binding. Arrow, start of the binding reaction;
asterisk, beginning of the washing with HBS buffer.
|
|
In reverse experiments, the authentic WW and the mutant Elp-derived
peptides were bound to the sensor surface and probed with
the purified
recombinant FFV Gag 1-154 protein (data not shown).
In full agreement
with the data presented above, FFV Gag 1-154
bound to the authentic wt
and, with a significantly lower affinity,
to the WA Elp-derived
peptides. Binding to the other mutant peptides
was not
observed.
In order to further substantiate the Gag-Elp interaction, Elp residues
1 to 65, which most probably correspond to the complete
cytoplasmic
domain of Elp, were expressed as a thioredoxin-Elp
fusion protein in
E. coli, purified, and analyzed for interaction
with FFV Gag
1-154. As anticipated, the thioredoxin-Elp fusion
protein exhibited a
significantly stronger binding to MA than
did the Elp WW
peptide (Fig.
8C). Most importantly, the off rate
was significantly
slower, with a half-life of about 7 min, indicative
of a stable Gag-Elp
interaction. The thioredoxin protein lacking
the Elp domain did not
show specific binding to the immobilized
FFV Gag 1-154, confirming the
specificity of the Elp-Gag interaction
described above (data not
shown).
To further confirm the specificity of the FFV Gag-Elp interaction, the
MA protein of HIV was bound to the sensor surface and
probed with the
wt and mutant Elp peptides. In these control experiments,
no evidence
for an interaction of FFV wt and mutant Elp peptides
with the unrelated
HIV MA protein was obtained, whereas a monospecific
antiserum directed
against recombinant HIV MA showed a strong
and specific interaction
(data not
shown).
 |
DISCUSSION |
We have used cEM of FFV and HFV to address the relationship of FV
structure to that of better characterized retroviruses such as B, C,
and D types and lentiviruses. FV share the heterogeneous size of
released retroviral particles, the lack of icosahedral symmetry, and
the radial arrangement of defined Gag domains with the other
retroviruses that have been examined (20, 47, 49, 52).
Comparative cEM of HFV and FFV revealed the FV MA layer, a novel
structural feature which was not visible in EM of thin sections. In
analogy to other retroviruses, the FV MA layer is considered to consist
primarily of the N-terminal Gag domain. This assumption is supported by
the difference in the sizes of the HFV and FFV MA layers, a difference
which likely corresponds to 130 additional residues in the N-terminal
region of HFV compared with FFV (Fig. 1D). In contrast, the central and
C-terminal Gag domains of the known FV are similar in size (Fig. 1D)
(42, 50), corresponding to the almost identical dimensions
of FFV and HFV capsids (Table 1). It is assumed that the central and
C-terminal regions of FV Gag are primarily involved in capsid formation
and genome binding (54). The size and shape of the FV
capsid structures do not match those of the hepadnaviruses despite
their functional similarities with retroviruses and FV
(2).
The second feature that distinguishes FV particles from those of other
retroviruses is the fact that the N-terminal domain of the Env
precursor Elp, about 16.5 kDa in size, is a virion-associated protein.
A similar observation has been previously reported for HFV (D. Lindemann, personal communication), whereas the much smaller N-terminal
signal peptides of other retroviruses are not part of the virion
(24).
Whereas the function of the classical signal peptide is considered to
be the targeting of Env into the lumen of the endoplasmatic reticulum
(24), the FV Elp appears to have additional functions. Our
present biosensor SPR work reveals a specific interaction of the
N-terminal sequences of the Elp with the N-terminal region of the FFV
Gag protein in vitro. Two conserved Trp residues in Elp were required
for binding. Corresponding interactions have not been shown for any
other retrovirus. The data obtained with the substitutions of Ala for
Trp in the FFV Elp peptides complement the results of genetic
experiments on HFV budding with the same amino acid substitutions (D. Lindemann, personal communication).
The on and off rates and affinities observed in the SPR studies with
the Elp peptides and the recombinant N-terminal Elp domain are expected
to yield specific and possibly even reversible interactions (25,
41). Virus morphogenesis and the formation of other higher-order protein complexes rely upon concerted effects of many specific interactions. These generate the metastable protein assemblies that
support the efficient disassembly that is required for infection (7).
The secondary structure of the Elp peptide is predicted by the computer
program DSC for discrimination of protein secondary structure
classes (28) to be identical to that in the full-length Env. The part of Elp which had been altered in the mutant peptides is
predicted to form a stable helix even when both Trp residues have been
replaced with Ala. Due to this intrinsic stability of the secondary
structure, the Elp peptides used for the assays may adopt a
conformation comparable to that in the viral particle. The
significantly stronger binding of Elp residues 1 to 65 in the context
of the fusion protein compared to the 30-mer Elp WW peptide indicates
that flanking residues and/or the overall folding of the cytoplasmic
domain of Elp are important for binding. By analogy, Elp-Gag binding
may be further modulated by the conformation and/or processing of the
Gag and Env precursor molecules.
Our data indicate that the N-terminal domain of Elp has an intrinsic
morphogenetic function in directing specific Env-MA interactions. Such
a function would require that the N terminus of Elp be located at the
cytoplasmic side of those membranes where FV budding takes place.
Consistently, subtilisin digests of purified FFV particles actually
showed that the N terminus of Elp is located inside the particle (data
not shown). Thus, the direct interaction of FV Elp with Gag may subsume
the role played by the membrane binding subdomain of other retrovirus
MA proteins. Detailed studies of the HIV-1 MA domain in the context of
the Gag precursor have shown that binding of MA to membranes involves
at least several domains of the MA protein (17).
The Elp-Gag interaction appears to be unique to FV, since heterologous
leader peptides in other retroviruses support the formation of
infectious particles. It is conceivable that the specificity of the FV
Elp-Gag interactions is the reason for the inability to pseudotype HFV
particles (38). Evidence for Env-Gag interactions has been
previously reported for other retroviruses; however, the interactions
involve the C-terminally located cytoplasmic tail of Env rather
than the leader peptide (17, 35, 44, 51).
Morphological evidence for an Env-Gag interaction was obtained only in
the FFV particles with distended morphology (Fig. 3 and Table 2). The
morphology of these particles clearly resembled that of the budding
forms of other retroviruses including FV (4, 6, 21, 22, 36, 38,
55). The envelope of the distended particles was incompletely
closed, and the particles were composed of a spherical portion and a
protruding tail (Fig. 3). We interpret them as FFV budding
intermediates that coisolated with the properly budded spherical FFV
particles. An alternative explanation that they represent disrupted
particles or fusion intermediates cannot be ruled out. Nevertheless,
the distended forms reveal structural features that may be present
transiently during morphogenesis even if these particles are dead-end
or abortive assemblies.
Provided that the distended FFV particles represent budding
intermediates, the Elp-MA layer interaction could serve the
morphogenetic role of targeting preformed FV capsids to the membrane
and/or concentrating Env trimers at the site of budding. The FV Elp-MA interaction may interfere with the cytoplasmic Gag targeting and retention of preassembled capsids. Such targeting and retention have
been shown to exist for Mason-Pfizer monkey virus Gag and are probably
mediated by the interaction of MA sequences with cellular proteins
(8). In other retroviruses, membrane targeting and binding
are attributed to the MA shell located directly under the viral
membrane (17). In FV, lateral Env-Env interactions seen in
cEM (Fig. 1 to 3) may provide the driving force that leads to budding
of FV particles, explaining the Env dependency of this process in FV
(4, 38). After budding is completed, the FV MA layer
should need to dissociate from the viral membrane as it remains
covalently linked to the capsid. This process may be modulated by
proteolysis, which would implicate that the mature Elp may have
functions different from those in the uncleaved Env precursor.
Additional experiments are required to determine the function of the
Elp-Gag interactions during morphogenesis and maturation.
In summary, the combination of cEM, immunoblotting, and SPR allowed us
to determine the structural features of FV particles, to identify the
virion-associated FFV Elp protein, and to characterize the molecular
basis of the FV Gag-Env interactions.
 |
ACKNOWLEDGMENTS |
T.W. and V.G. contributed equally to this study.
This study was supported by the Deutsche Forschungsgemeinschaft grants
LO 700/1-2 to M.L. and Fu 354/1-1 to S.D.F. and a Wellcome Trust
Programme grant to S.D.F. S.D.F. is a Wellcome Trust Principal Research Fellow.
We thank Dirk Lindemann for communicating his results prior to
publication. We are grateful to Erika Mancini (EMBL) and Felix deHaas
(EMBL) for discussions and help with the CTF correction, Norbert
Avemarie (Merck) for help in SPR studies, Helmut Bannert (DKFZ) for
excellent technical assistance, and Harald zur Hausen for continuous support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Abteilung
Retrovirale Genexpression, Forschungsschwerpunkt Angewandte
Tumorvirologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld
242, 69120 Heidelberg, Germany. Phone: 49-6221-424853. Fax:
49-6221-424865. E-mail: m.loechelt{at}dkfz-heidelberg.de.
 |
REFERENCES |
| 1.
|
Alke, A.,
A. Schwantes,
M. Zemba,
R. M. Flügel, and M. Löchelt.
2000.
Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus.
Virology
275:170-176[CrossRef][Medline].
|
| 2.
|
Baker, T. S.,
N. H. Olson, and S. D. Fuller.
1999.
Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs.
Microbiol. Mol. Biol. Rev.
63:862-922[Abstract/Free Full Text].
|
| 3.
|
Baldwin, D. N., and M. L. Linial.
1999.
Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.
J. Virol.
73:63687-63693.
|
| 4.
|
Baldwin, D. N., and M. L. Linial.
1998.
The roles of Pol and Env in the assembly pathway of human foamy virus.
J. Virol.
72:3658-3665[Abstract/Free Full Text].
|
| 5.
|
Bodem, J.,
M. Zemba, and R. M. Flügel.
1998.
Nuclear localization of the functional Bel 1 transactivator but not of the gag proteins of the feline foamy virus.
Virology
251:22-27[CrossRef][Medline].
|
| 6.
|
Bugelski, P. J.,
B. E. Maleeff,
A. M. Klinkner,
J. Ventre, and T. K. Hart.
1995.
Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1.
AIDS Res. Hum. Retrovir.
11:55-64[Medline].
|
| 7.
|
Caspar, D. L. D., and A. Klug.
1962.
Physical principles in the construction of regular viruses.
Cold Spring Harbor Symp. Quant. Biol.
27:1-24[Abstract/Free Full Text].
|
| 8.
|
Choi, G.,
S. Park,
B. Choi,
S. Hong,
J. Lee,
E. Hunter, and S. S. Rhee.
1999.
Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.
J. Virol.
73:5431-5437[Abstract/Free Full Text].
|
| 9.
|
Coffin, J. M.
1996.
Retroviridae: the viruses and their replication, p. 1767-1847.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Raven Press, New York, N.Y.
|
| 10.
|
Conte, M. R., and S. Matthews.
1998.
Retroviral matrix proteins: a structural perspective.
Virology
246:191-198[CrossRef][Medline].
|
| 11.
|
de Haas, F.,
A. O. Paatero,
L. Mindich,
D. H. Bamford, and S. D. Fuller.
1999.
A symmetry mismatch at the site of RNA packaging by the polymerase complex of dsRNA bacteriophage phi-6.
J. Mol. Biol.
294:357-372[CrossRef][Medline].
|
| 12.
|
Enssle, J.,
N. Fischer,
A. Moebes,
B. Mauer,
U. Smola, and A. Rethwilm.
1997.
Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.
J. Virol.
71:7312-7317[Abstract].
|
| 13.
|
Erickson, H. P., and A. Klug.
1971.
Measurement and compensation of defocusing and aberrations by Fourier processing of micrographs.
Philos. Trans. R. Soc. Lond. B Biol. Sci.
261:105-118.
|
| 13a.
|
Ferlenghi, I.,
M. Clarke,
T. Ruttan,
S. L. Allison,
J. Schalich,
F. X. Heinz,
S. C. Harrison,
F. A. Rey, and S. D. Fuller.
2001.
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.
Mol. Cell
7:593-602[CrossRef][Medline].
|
| 14.
|
Fischer, N.,
M. Heinkelein,
D. Lindemann,
J. Enssle,
C. Baum,
E. Werder,
H. Zentgraf,
J. G. Muller, and A. Rethwilm.
1998.
Foamy virus particle formation.
J. Virol.
72:1610-1615[Abstract/Free Full Text].
|
| 15.
|
Frank, J.,
M. Radermacher,
P. Penczek,
J. Zhu,
Y. Li,
M. Ladjadj, and A. Leith.
1996.
SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields.
J. Struct. Biol.
116:190-199[CrossRef][Medline].
|
| 16.
|
Frankel, A. D., and J. A. Young.
1998.
HIV-1: fifteen proteins and an RNA.
Annu. Rev. Biochem.
67:1-25[CrossRef][Medline].
|
| 17.
|
Freed, E. O.
1998.
HIV-1 Gag proteins: diverse functions in the virus life cycle.
Virology
251:1-15[CrossRef][Medline].
|
| 18.
|
Fuller, S. D.,
J. A. Berriman,
S. J. Butcher, and B. E. Gowen.
1995.
Low pH induces the swivelling of the glycoprotein heterodimers in the Semliki Forest virus spike complex.
Cell
81:715-725[CrossRef][Medline].
|
| 19.
|
Fuller, S. D.,
S. J. Butcher,
R. H. Cheng, and T. S. Baker.
1996.
Three-dimensional reconstruction of icosahedral particles: the uncommon line.
J. Struct. Biol.
116:48-65[CrossRef][Medline].
|
| 20.
|
Fuller, S. D.,
T. Wilk,
B. E. Gowen,
H.-G. Kräusslich, and V. M. Vogt.
1997.
Cryo-electron microscopy reveals ordered domains within the immature HIV-1 particle.
Curr. Biol.
7:729-738[CrossRef][Medline].
|
| 21.
|
Gelderblom, H. R.
1991.
Assembly and morphology of HIV: potential effect of structure on viral function.
AIDS
5:617-638[Medline].
|
| 22.
|
Gelderblom, H. R.,
E. H. S. Hausmann,
M. Örzel,
G. Pauli, and M. A. Koch.
1987.
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology
156:171-176[CrossRef][Medline].
|
| 23.
|
Giron, M. L.,
S. Colas,
J. Wybier,
F. Rozain, and R. Emanoil-Ravier.
1997.
Expression and maturation of human foamy virus Gag precursor polypeptides.
J. Virol.
71:1635-1639[Abstract].
|
| 24.
|
Hunter, E., and R. Swanstrom.
1990.
Retrovirus envelope glycoproteins.
Curr. Top. Microbiol. Immunol.
157:187-253[Medline].
|
| 25.
|
Jelonek, M. T.,
K. Natarajan, and D. H. Margulies.
2000.
Physical measurements of the interaction of MHC molecules and T-cell receptors, p. 115-125.
In
K. Nagata, and H. Handa (ed.), Real-time analysis of biomolecular interactions application of BIACORE. Springer-Verlag, Tokyo, Japan.
|
| 26.
|
Johnsson, B., and G. Malmqvist.
1992.
Real-time biospecific interaction analysis. The integration of surface plasmon resonance detection, general biospecific interface chemistry, and microfluidics into one analytical system, p. 291-336.
In
A. Turner (ed.), Advances in biosensors. JAI Press Ltd., London, United Kingdom.
|
| 27.
|
Johnsson, B.,
S. Lofas, and G. Lindquist.
1991.
Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors.
Anal. Biochem.
198:268-277[CrossRef][Medline].
|
| 28.
|
King, R. D.,
M. Saqi,
R. Sayle, and M. J. Sternberg.
1997.
DSC: public domain protein secondary structure predication.
Comput. Appl. Biosci.
13:473-474[Free Full Text].
|
| 29.
|
Konvalinka, J.,
M. Löchelt,
H. Zentgraf,
R. M. Flügel, and H.-G. Kräusslich.
1995.
Active spumavirus proteinase is essential for virus infectivity but not for formation of the Pol polyprotein.
J. Virol.
69:7264-7268[Abstract].
|
| 30.
|
Lecellier, C. H., and A. Saib.
2000.
Foamy viruses: between retroviruses and pararetroviruses.
Virology
271:1-8[CrossRef][Medline].
|
| 31.
|
Linial, M. L.
1999.
Foamy viruses are unconventional retroviruses.
J. Virol.
73:1747-1755[Free Full Text].
|
| 32.
|
Löchelt, M., and R. Flügel.
1995.
The molecular biology of primate spumaviruses, p. 361-397.
In
J. A. Levy (ed.), The Retroviridae, vol. 4. Plenum Press, New York, N.Y.
|
| 33.
|
Löchelt, M.,
H. Zentgraf, and R. M. Flügel.
1991.
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.
Virology
184:43-54[CrossRef][Medline].
|
| 34.
|
Morozov, V. A.,
T. D. Copeland,
K. Nagashima,
M. A. Gonda, and S. Oroszlan.
1997.
Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.
Virology
228:307-317[CrossRef][Medline].
|
| 35.
|
Murakami, T., and E. O. Freed.
2000.
Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and -helix 2 of the gp41 cytoplasmic tail.
J. Virol.
74:3548-3554[Abstract/Free Full Text].
|
| 36.
|
Nermut, M. V., and D. J. Hockley.
1996.
Comparative morphology and structural classification of retroviruses.
Curr. Top. Microbiol. Immunol.
214:1-24[Medline].
|
| 37.
|
Pfrepper, K. I.,
M. Löchelt,
H. R. Rackwitz,
M. Schnölzer,
H. Heid, and R. M. Flügel.
1999.
Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.
J. Virol.
73:7907-7911[Abstract/Free Full Text].
|
| 38.
|
Pietschmann, T.,
M. Heinkelein,
M. Heldmann,
H. Zentgraf,
A. Rethwilm, and D. Lindemann.
1999.
Foamy virus capsids require the cognate envelope protein for particle export.
J. Virol.
73:2613-2621[Abstract/Free Full Text].
|
| 39.
|
Rethwilm, A.
1995.
Regulation of foamy virus gene expression.
Curr. Top. Microbiol. Immunol.
193:1-24[Medline].
|
| 40.
|
Sakalian, M., and E. Hunter.
1998.
Molecular events in the assembly of retrovirus particles.
Adv. Exp. Med. Biol.
440:329-339[Medline].
|
| 41.
|
Slansky, J. E.,
F. M. Rattis,
L. F. Boyd,
T. Fahmy,
E. M. Jaffee,
J. P. Schneck,
D. H. Margulies, and D. M. Pardoll.
2000.
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
Immunity
13:529-538[CrossRef][Medline].
|
| 42.
|
Tobaly-Tapiero, J.,
P. Bittoun,
M. Neves,
M. C. Guillemin,
C. H. Lecellier,
F. Puvion-Dutilleul,
B. Gicquel,
S. Zientara,
M. L. Giron,
H. de The, and A. Saib.
2000.
Isolation and characterization of an equine foamy virus.
J. Virol.
74:4064-4073[Abstract/Free Full Text].
|
| 43.
|
Turner, B. G., and M. F. Summers.
1999.
Structural biology of HIV.
J. Mol. Biol.
285:1-32[CrossRef][Medline].
|
| 44.
|
Vincent, M. J.,
L. R. Melsen,
A. S. Martin, and R. W. Compans.
1999.
Intracellular interaction of simian immunodeficiency virus Gag and Env proteins.
J. Virol.
73:8138-8144[Abstract/Free Full Text].
|
| 45.
|
Vogt, V. M.
1997.
Retroviral virions and genomes, p. 27-70.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 46.
|
Wilk, T.,
F. deHaas,
A. Wagner,
A. Alke,
T. Rutten,
S. D. Fuller,
R. M. Flügel, and M. Löchelt.
2000.
The intact retroviral Env glycoprotein of human foamy virus is a trimer.
J. Virol.
74:2885-2887[Abstract/Free Full Text].
|
| 47.
|
Wilk, T., and S. D. Fuller.
1999.
Towards the structure of the human immunodeficiency virus: divide and conquer.
Curr. Opin. Struct. Biol.
9:231-243[CrossRef][Medline].
|
| 48.
|
Wilk, T.,
B. Gowen, and S. D. Fuller.
1999.
Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.
J. Virol.
73:1931-1940[Abstract/Free Full Text].
|
| 49.
|
Wilk, T.,
I. Gross,
B. E. Gowen,
T. Rutten,
F. de Haas,
R. Welker,
H.-G. Kräusslich,
P. Boulanger, and S. D. Fuller.
2000.
The organization of immature HIV-1.
J. Virol.
75:759-771[Abstract/Free Full Text].
|
| 50.
|
Winkler, I.,
J. Bodem,
L. Haas,
M. Zemba,
H. Delius,
R. Flower,
R. M. Flügel, and M. Löchelt.
1997.
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses.
J. Virol.
71:6727-6741[Abstract].
|
| 51.
|
Wyma, D. J.,
A. Kotov, and C. Aiken.
2000.
Evidence for a stable interaction of gp41 with Pr55Gag in immature human immunodeficiency virus type 1 particles.
J. Virol.
74:9381-9387[Abstract/Free Full Text].
|
| 52.
|
Yeager, M.,
E. M. Wilson-Kubalek,
S. G. Weiner,
P. O. Brown, and A. Rein.
1998.
Supramolecular design of native and immature murine leukemia virus reveals by electron cryo-microscopy.
Proc. Natl. Acad. Sci. USA
95:7299-7304[Abstract/Free Full Text].
|
| 53.
|
Yu, S. F.,
D. N. Baldwin,
S. R. Gwynn,
S. Yendapalli, and M. L. Linial.
1996.
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.
Science
271:1579-1582[Abstract].
|
| 54.
|
Yu, S. F.,
K. Edelmann,
R. K. Strong,
A. Moebes,
A. Rethwilm, and M. L. Linial.
1996.
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains.
J. Virol.
70:8255-8262[Abstract].
|
| 55.
|
Zemba, M.,
T. Wilk,
T. Rutten,
A. Wagner,
R. Flügel, and M. Löchelt.
1998.
The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.
Virology
247:7-13[CrossRef][Medline].
|
| 56.
|
Zemba, M.,
A. Alke,
J. Bodem,
I. G. Winkler,
R. L. P. Flower,
K.-I. Pfrepper,
H. Delius,
R. M. Flügel, and M. Löchelt.
2000.
Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.
Virology
266:150-156[CrossRef][Medline].
|
| 57.
|
Zhou, W., and M. D. Resh.
1996.
Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
J. Virol.
70:8540-8548[Abstract].
|
Journal of Virology, September 2001, p. 7995-8007, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.7995-8007.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stange, A., Luftenegger, D., Reh, J., Weissenhorn, W., Lindemann, D.
(2008). Subviral Particle Release Determinants of Prototype Foamy Virus. J. Virol.
82: 9858-9869
[Abstract]
[Full Text]
-
Mannigel, I., Stange, A., Zentgraf, H., Lindemann, D.
(2007). Correct Capsid Assembly Mediated by a Conserved YXXLGL Motif in Prototype Foamy Virus Gag Is Essential for Infectivity and Reverse Transcription of the Viral Genome. J. Virol.
81: 3317-3326
[Abstract]
[Full Text]
-
Duda, A., Luftenegger, D., Pietschmann, T., Lindemann, D.
(2006). Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.. J. Virol.
80: 8158-8167
[Abstract]
[Full Text]
-
Stanke, N., Stange, A., Luftenegger, D., Zentgraf, H., Lindemann, D.
(2005). Ubiquitination of the Prototype Foamy Virus Envelope Glycoprotein Leader Peptide Regulates Subviral Particle Release. J. Virol.
79: 15074-15083
[Abstract]
[Full Text]
-
Cartellieri, M., Herchenroder, O., Rudolph, W., Heinkelein, M., Lindemann, D., Zentgraf, H., Rethwilm, A.
(2005). N-Terminal Gag Domain Required for Foamy Virus Particle Assembly and Export. J. Virol.
79: 12464-12476
[Abstract]
[Full Text]
-
Luftenegger, D., Picard-Maureau, M., Stanke, N., Rethwilm, A., Lindemann, D.
(2005). Analysis and Function of Prototype Foamy Virus Envelope N Glycosylation. J. Virol.
79: 7664-7672
[Abstract]
[Full Text]
-
Stange, A., Mannigel, I., Peters, K., Heinkelein, M., Stanke, N., Cartellieri, M., Gottlinger, H., Rethwilm, A., Zentgraf, H., Lindemann, D.
(2005). Characterization of Prototype Foamy Virus Gag Late Assembly Domain Motifs and Their Role in Particle Egress and Infectivity. J. Virol.
79: 5466-5476
[Abstract]
[Full Text]
-
Neuman, B. W., Adair, B. D., Burns, J. W., Milligan, R. A., Buchmeier, M. J., Yeager, M.
(2005). Complementarity in the Supramolecular Design of Arenaviruses and Retroviruses Revealed by Electron Cryomicroscopy and Image Analysis. J. Virol.
79: 3822-3830
[Abstract]
[Full Text]
-
Geiselhart, V., Bastone, P., Kempf, T., Schnolzer, M., Lochelt, M.
(2004). Furin-Mediated Cleavage of the Feline Foamy Virus Env Leader Protein. J. Virol.
78: 13573-13581
[Abstract]
[Full Text]
-
Duda, A., Stange, A., Luftenegger, D., Stanke, N., Westphal, D., Pietschmann, T., Eastman, S. W., Linial, M. L., Rethwilm, A., Lindemann, D.
(2004). Prototype Foamy Virus Envelope Glycoprotein Leader Peptide Processing Is Mediated by a Furin-Like Cellular Protease, but Cleavage Is Not Essential for Viral Infectivity. J. Virol.
78: 13865-13870
[Abstract]
[Full Text]
-
Roy, J., Rudolph, W., Juretzek, T., Gartner, K., Bock, M., Herchenroder, O., Lindemann, D., Heinkelein, M., Rethwilm, A.
(2003). Feline Foamy Virus Genome and Replication Strategy. J. Virol.
77: 11324-11331
[Abstract]
[Full Text]
-
Briggs, J. A. G., Wilk, T., Fuller, S. D.
(2003). Do lipid rafts mediate virus assembly and pseudotyping?. J. Gen. Virol.
84: 757-768
[Abstract]
[Full Text]
-
Shaw, K. L., Lindemann, D., Mulligan, M. J., Goepfert, P. A.
(2003). Foamy Virus Envelope Glycoprotein Is Sufficient for Particle Budding and Release. J. Virol.
77: 2338-2348
[Abstract]
[Full Text]
-
Lecellier, C.-H., Neves, M., Giron, M.-L., Tobaly-Tapiero, J., Saib, A.
(2002). Further Characterization of Equine Foamy Virus Reveals Unusual Features among the Foamy Viruses. J. Virol.
76: 7220-7227
[Abstract]
[Full Text]